Evidence map›Paper›PMID 33737920›Full record

ReviewFrontiers in microbiology2021

Applications of Machine Learning in Human Microbiome Studies: A Review on Feature Selection, Biomarker Identification, Disease Prediction and Treatment.

Laura Judith Marcos-Zambrano, Kanita Karaduzovic-Hadziabdic, Tatjana Loncar Turukalo, Piotr Przymus, Vladimir Trajkovik, Oliver Aasmets, Magali Berland, Aleksandra Gruca, Jasminka Hasic, Karel Hron and 19 more

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 204 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
204citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

204 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Worldwide research trends on theFrontiers in immunology · 2026
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Review
  12. Review
  13. From trees to graphs: rethinking phylogeny in microbiome prediction.Applied and environmental microbiology · 2026
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Microbiome-guided cancer immunotherapy: immune mechanisms, resistance pathways, and translational opportunities for precision oncology.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review

144 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Laura Judith Marcos-ZambranoComputational Biology Group, Precision Nutrition and Cancer Research Program, IMDEA Food Institute, Madrid, Spain.
Kanita Karaduzovic-HadziabdicFaculty of Engineering and Natural Sciences, International University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Tatjana Loncar TurukaloFaculty of Technical Sciences, University of Novi Sad, Novi Sad, Serbia.
Piotr PrzymusFaculty of Mathematics and Computer Science, Nicolaus Copernicus University, Toruń, Poland.
Vladimir TrajkovikFaculty of Computer Science and Engineering, Ss. Cyril and Methodius University, Skopje, North Macedonia.
Oliver AasmetsInstitute of Genomics, Estonian Genome Centre, University of Tartu, Tartu, Estonia.
Magali BerlandUniversité Paris-Saclay, INRAE, MGP, Jouy-en-Josas, France.
Aleksandra GrucaDepartment of Computer Networks and Systems, Silesian University of Technology, Gliwice, Poland.
Jasminka HasicUniversity Sarajevo School of Science and Technology, Sarajevo, Bosnia and Herzegovina.
Karel HronDepartment of Mathematical Analysis and Applications of Mathematics, Palacký University, Olomouc, Czechia.
Thomas KlammsteinerDepartment of Microbiology, University of Innsbruck, Innsbruck, Austria.
Mikhail KolevSouth West University "Neofit Rilski", Blagoevgrad, Bulgaria.
Leo LahtiDepartment of Computing, University of Turku, Turku, Finland.
Marta B LopesNOVA Laboratory for Computer Science and Informatics (NOVA LINCS), FCT, UNL, Caparica, Portugal.
Victor MorenoOncology Data Analytics Program, Catalan Institute of Oncology (ICO) Barcelona, Spain.
Irina NaskinovaSouth West University "Neofit Rilski", Blagoevgrad, Bulgaria.
Elin OrgInstitute of Genomics, Estonian Genome Centre, University of Tartu, Tartu, Estonia.
Inês PaciênciaEPIUnit - Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal.
Georgios PapoutsoglouDepartment of Computer Science, University of Crete, Heraklion, Greece.
Rajesh ShigdelDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Blaz StresGroup for Microbiology and Microbial Biotechnology, Department of Animal Science, University of Ljubljana, Ljubljana, Slovenia.
Baiba VilneBioinformatics Research Unit, Riga Stradins University, Riga, Latvia.
Malik YousefDepartment of Information Systems, Zefat Academic College, Zefat, Israel.
Eftim ZdravevskiFaculty of Computer Science and Engineering, Ss. Cyril and Methodius University, Skopje, North Macedonia.
Ioannis TsamardinosDepartment of Computer Science, University of Crete, Heraklion, Greece.
Enrique Carrillo de Santa PauComputational Biology Group, Precision Nutrition and Cancer Research Program, IMDEA Food Institute, Madrid, Spain.
Marcus J ClaessonSchool of Microbiology & APC Microbiome Ireland, University College Cork, Cork, Ireland.
Isabel Moreno-IndiasUnidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Clínico Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain.
Jaak TruuInstitute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The number of microbiome-related studies has notably increased the availability of data on human microbiome composition and function. These studies provide the essential material to deeply explore host-microbiome associations and their relation to the development and progression of various complex diseases. Improved data-analytical tools are needed to exploit all information from these biological datasets, taking into account the peculiarities of microbiome data, i.e., compositional, heterogeneous and sparse nature of these datasets. The possibility of predicting host-phenotypes based on taxonomy-informed feature selection to establish an association between microbiome and predict disease states is beneficial for personalized medicine. In this regard, machine learning (ML) provides new insights into the development of models that can be used to predict outputs, such as classification and prediction in microbiology, infer host phenotypes to predict diseases and use microbial communities to stratify patients by their characterization of state-specific microbial signatures. Here we review the state-of-the-art ML methods and respective software applied in human microbiome studies, performed as part of the COST Action ML4Microbiome activities. This scoping review focuses on the application of ML in microbiome studies related to association and clinical use for diagnostics, prognostics, and therapeutics. Although the data presented here is more related to the bacterial community, many algorithms could be applied in general, regardless of the feature type. This literature and software review covering this broad topic is aligned with the scoping review methodology. The manual identification of data sources has been complemented with: (1) automated publication search through digital libraries of the three major publishers using natural language processing (NLP) Toolkit, and (2) an automated identification of relevant software repositories on GitHub and ranking of the related research papers relying on learning to rank approach.

Indexed as

biomarker identificationdisease predictionfeature selectionmachine learningmicrobiome

Identifiers

PMID33737920
PMCPMC7962872

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.